Zobrazeno 1 - 10
of 324
pro vyhledávání: '"David V. Glidden"'
Autor:
Scott Lu, Michael J. Peluso, David V. Glidden, Michelle C. Davidson, Kara Lugtu, Jesus Pineda-Ramirez, Michel Tassetto, Miguel Garcia-Knight, Amethyst Zhang, Sarah A. Goldberg, Jessica Y. Chen, Maya Fortes-Cobby, Sara Park, Ana Martinez, Matthew So, Aidan Donovan, Badri Viswanathan, Rebecca Hoh, Kevin Donohue, David R. McIlwain, Brice Gaudiliere, Khamal Anglin, Brandon C. Yee, Ahmed Chenna, John W. Winslow, Christos J. Petropoulos, Steven G. Deeks, Melissa Briggs-Hagen, Raul Andino, Claire M. Midgley, Jeffrey N. Martin, Sharon Saydah, J. Daniel Kelly
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract To understand the roles of acute-phase viral dynamics and host immune responses in post-acute sequelae of SARS-CoV-2 infection (PASC), we enrolled 136 participants within 5 days of their first positive SARS-CoV-2 real-time PCR test. Particip
Externí odkaz:
https://doaj.org/article/f3f4553901f94b25adaf0ba288ffedaa
Autor:
Olga Tymofiyeva, Benjamin S. Sipes, Tracy Luks, Elissa J. Hamlat, Tara E. Samson, Thomas J. Hoffmann, David V. Glidden, Angela Jakary, Yi Li, Tiffany Ngan, Eva Henje, Tony T. Yang
Publikováno v:
Frontiers in Psychology, Vol 15 (2024)
IntroductionThis study evaluated changes in the white matter of the brain and psychological health variables, resulting from a neuroscience-based mindfulness intervention, the Training for Awareness, Resilience, and Action (TARA), in a population of
Externí odkaz:
https://doaj.org/article/b9a17612556140ee9b2c011cc9298e1d
Autor:
Linxuan Wu, Matilda Saina, Clare Brown, David Chege, Deborah Donnell, David V. Glidden, Kenneth Ngure, Nelly R. Mugo, Nina Akelo, Torin Schaafsma, Peter L. Anderson, Kenneth K. Mugwanya
Publikováno v:
Frontiers in Reproductive Health, Vol 6 (2024)
BackgroundOral pre-exposure prophylaxis (PrEP) using co-formulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) is a potent HIV prevention method for men and women, with its efficacy highly dependent on adherence. A pivotal HIV efficac
Externí odkaz:
https://doaj.org/article/32652e481b6342af8837760f8a6bc65f
Autor:
Julia H. Raney, Abubakr A. Al-Shoaibi, Iris Y. Shao, Kyle T. Ganson, Alexander Testa, Dylan B. Jackson, Jinbo He, David V. Glidden, Jason M. Nagata
Publikováno v:
Journal of Eating Disorders, Vol 11, Iss 1, Pp 1-9 (2023)
Abstract Background Racial and ethnic discrimination are known stressors and are associated with negative psychological and physical health outcomes. Previous studies have found relationships between racial/ethnic discrimination and binge-eating diso
Externí odkaz:
https://doaj.org/article/d12711d418fe4c84947f757e3387251d
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Active-control trials, where an experimental treatment is compared with an established treatment, are performed when the inclusion of a placebo control group is deemed to be unethical. For time-to-event outcomes, the primary estimand is usua
Externí odkaz:
https://doaj.org/article/64cf68fd6e1745799dce47f7cc3254de
Autor:
Olga Tymofiyeva, Melody Y. Hu, Benjamin S. Sipes, Angela Jakary, David V. Glidden, Namasvi Jariwala, Sarina Bhandari, Kendall C. Parks, Ca Nguyen, Eva Henje, Tony T. Yang
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Social distancing, home confinement, economic challenges, and COVID-19-related illness and deaths during the COVID-19 pandemic can significantly affect mental health in youth. One promising approach to reduce anxiety and depression in adolescents is
Externí odkaz:
https://doaj.org/article/0f4a15d377984318ab30e44f769d5610
Autor:
Maria Garcia-Cremades, Craig W. Hendrix, Priya Jayachandran, Natasha Strydom, Leah Jarlsberg, Robert Grant, Connie L. Celum, Michael Martin, Jared M. Baeten, Jeanne Marrazzo, Peter Anderson, Kachit Choopanya, Suphak Vanichseni, David V. Glidden, Radojka M. Savic
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1801 (2022)
The World Health Organization recommends pre-exposure prophylaxis (PrEP) for individuals at substantial risk of HIV infection. The aim of this analysis is to quantify the individual risk of HIV infection over time, using a large database of high-risk
Externí odkaz:
https://doaj.org/article/34908a46f54d4d6fbafe83e2539c36ed
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-16 (2016)
Abstract Background In many studies, some information might not be available for the whole cohort, some covariates, or even the outcome, might be ascertained in selected subsamples. These studies are part of a broad category termed two-phase studies.
Externí odkaz:
https://doaj.org/article/ec3caf773d1f4b8090ff41461ab4fb8d
Publikováno v:
Clinical Infectious Diseases. 76:1850-1853
Using intraerythrocytic tenofovir-diphosphate data from the emtricitabine/tenofovir disoproxil fumarate arms of HIV Prevention Trials Network (HPTN) 083 (men) and HPTN 084 (women), approximately 99% efficacy was achieved at a lower adherence threshol
Autor:
Kelly A Johnson, Hideaki Okochi, Mireya Arreguin, Joseph Watabe, David V Glidden, Anindita Chattopadhyay, Elizabeth Imbert, Matthew D Hickey, Monica Gandhi, Matthew Spinelli
Publikováno v:
Clinical Infectious Diseases. 76:930-933
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This sugges